MEGAN DICKINSON: Open Payments
NPI 1508291048 · LUFKIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 13 payments from 6 companies in 2025. Trend: 2023 $318 · 2024 $681 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $117 |
| ABBVIE INC. | 1 | $95 |
| Inspire Medical Systems, Inc. | 2 | $79 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Novo Nordisk Inc | 3 | $59 |
| Lilly USA, LLC | 1 | $21 |
Products named: QULIPTA, General - EP, INSPIRE, Ozempic, AIRSUPRA, FARAPULSE, JARDIANCE, FARXIGA.
Industry payments across TX — which companies pay providers there.
